Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001575705-22-000499
Filing Date
2022-07-13
Accepted
2022-07-13 12:57:58
Documents
46
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 spk_10k.htm   iXBRL 10-K/A 666622
2 ex4_5.htm EX-4.5 17524
3 ex31_1.htm EX-31.1 15060
4 ex31_2.htm EX-31.2 14296
5 ex32_1.htm EX-32.1 6250
6 ex32_2.htm EX-32.2 5103
  Complete submission text file 0001575705-22-000499.txt   2794923

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE spkau-20211231.xsd EX-101.SCH 25844
8 XBRL CALCULATION FILE spkau-20211231_cal.xml EX-101.CAL 27836
9 XBRL DEFINITION FILE spkau-20211231_def.xml EX-101.DEF 88515
10 XBRL LABEL FILE spkau-20211231_lab.xml EX-101.LAB 170968
11 XBRL PRESENTATION FILE spkau-20211231_pre.xml EX-101.PRE 136687
40 EXTRACTED XBRL INSTANCE DOCUMENT spk_10k_htm.xml XML 294443
Mailing Address ROOM 368, 302 BUWEI 211 FUTE NORTH ROAD, SHANGHAI F4 200131
Business Address ROOM 368, 302 BUWEI 211 FUTE NORTH ROAD, SHANGHAI F4 200131 86 13439129879
SPK Acquisition Corp. (Filer) CIK: 0001848097 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40462 | Film No.: 221080681
SIC: 2836 Biological Products, (No Diagnostic Substances)